No photo of Chin-Hsin Hsu

View Scopus Profile

Chin-Hsin Hsu

Doctor

  • 405 Citations
  • 13 h-Index
20042019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 國立成功大學臨床醫學研究所博士

Experience

  • 2012年08月 ~迄今 重症加護科醫師
  • 1999年08月 ~2012年07月 心臟血管科醫師

Fingerprint Dive into the research topics where Chin-Hsin Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 405 Citations
  • 13 h-Index
  • 32 Article
  • 3 Review article
  • 1 Letter

2018 TSOC guideline focused update on diagnosis and treatment of pulmonary arterial hypertension

TSOC pulmonary hypertension committee, 2019 Dec, In : Journal of the Formosan Medical Association. 118, 12, p. 1584-1609 26 p.

Research output: Contribution to journal › Article

Open Access
    • 1 Citation (Scopus)

    Exendin-4 improves cardiovascular function and survival in flow-induced pulmonary hypertension

    Roan, J. N., Hsu, C. H., Fang, S. Y., Tsai, H. W., Luo, C. Y., Huang, C. C. & Lam, C. F., 2018 Apr, In : Journal of Thoracic and Cardiovascular Surgery. 155, 4, p. 1661-1669.e4

    Research output: Contribution to journal › Article

    • 3 Citations (Scopus)

    Microrna-21 is associated with the severity of right ventricular dysfunction in patients with hypoxia-induced pulmonary hypertension

    Chang, W. T., Hsu, C. H., Huang, T. L., Tsai, Y. C., Chiang, C. Y., Chen, Z. C. & Shih, J. Y., 2018 Nov, In : Acta Cardiologica Sinica. 34, 6, p. 511-517 7 p.

    Research output: Contribution to journal › Article

    • 7 Citations (Scopus)

    Hemodynamic, biological, and right ventricular functional changes following intraatrial shunt repair in patients with flow-induced pulmonary hypertension

    Hsu, C. H., Roan, J. N., Wang, J. N., Huang, C. C., Shih, C. J., Chen, J. H., Wu, J. M. & Lam, C. F., 2017 Jul 1, In : Congenital Heart Disease. 12, 4, p. 533-539 7 p.

    Research output: Contribution to journal › Article

    • 1 Citation (Scopus)

    High-dose calcineurin inhibitor-free everolimus as a maintenance regimen for heart transplantation may be a risk factor for Pneumocystis pneumonia

    Hu, Y. N., Lee, N. Y., Roan, J. N., Hsu, C. H. & Luo, C. Y., 2017 Aug, In : Transplant Infectious Disease. 19, 4, e12709.

    Research output: Contribution to journal › Article

    • 3 Citations (Scopus)